2006
DOI: 10.1016/j.ejca.2006.01.024
|View full text |Cite
|
Sign up to set email alerts
|

Activating anti-CD40 antibodies induce tumour invasion by cytotoxic T-lymphocytes and inhibition of tumour growth in experimental liver cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
5
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 24 publications
1
5
0
Order By: Relevance
“…Our results agree with prior studies that suggest an important effect of CD40 on leukocyte migration across endothelial cells and into tumors (55,69). The defect in T-cell migration to the CNS in CD40 Ϫ/Ϫ mice is also consistent with studies on CD4 ϩ T-cell trafficking during experimental autoimmune encephalomyelitis (1,3,26,31,68) and suggest a critical role for CD40-CD40L interactions in the regulation of lymphocyte movement into the CNS.…”
Section: Discussionsupporting
confidence: 83%
“…Our results agree with prior studies that suggest an important effect of CD40 on leukocyte migration across endothelial cells and into tumors (55,69). The defect in T-cell migration to the CNS in CD40 Ϫ/Ϫ mice is also consistent with studies on CD4 ϩ T-cell trafficking during experimental autoimmune encephalomyelitis (1,3,26,31,68) and suggest a critical role for CD40-CD40L interactions in the regulation of lymphocyte movement into the CNS.…”
Section: Discussionsupporting
confidence: 83%
“…Clinical trials of early phases have shown that this approach is safe and provides clinical efficacy in addition to immune responses 16 17. Our group has recently described stimulating monoclonal antibodies against CD40 as an effective treatment against liver cancer in a rat model 12. The data suggest that the observed effects are due to activation of CD8 + , CD4 + and NK cells, the stimulation of leukocyte adhesion to tumour vessels and finally their migration into the tumour.…”
Section: Discussionmentioning
confidence: 99%
“…Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, accounting for 85% to 90% of primary liver cancers 1, 2. The standard HCC treatments include surgical resection, liver transplantation, immunotherapy, radiotherapy and chemotherapy 3, 4. However, none of these treatments is very effective, and a large proportion of HCC patients have a poor prognosis because of rapid metastasis 4, 5.…”
Section: Introductionmentioning
confidence: 99%